Cargando…

Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis

PURPOSE: Increased lipoprotein-associated phospholipase A2 (Lp-PLA2) activity and Rho kinase activity may be associated with atherosclerosis. The principal aim of this study was to examine whether darapladib (a selective Lp-PLA2 inhibitor) could reduce the elevated Lp-PLA2 and Rho kinase activity in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Juan, Xu, Dong-Ling, Liu, Xiao-Bo, Bi, Shao-jie, Zhao, Tong, Sui, Shu-Jian, Ji, Xiao-Ping, Lu, Qing-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740522/ https://www.ncbi.nlm.nih.gov/pubmed/26847282 http://dx.doi.org/10.3349/ymj.2016.57.2.321

Ejemplares similares

The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism
por: Oh, Mihee, et al.
Publicado: (2023)

Active site competition is the mechanism for the inhibition of lipoprotein-associated phospholipase A(2) by detergent micelles or lipoproteins and for the efficacy reduction of darapladib
por: Zhuo, Shaoqiu, et al.
Publicado: (2020)

Effect of Darapladib Treatment on Endarterectomy Carotid Plaque Lipoprotein-Associated Phospholipase A(2) Activity: A Randomized, Controlled Trial
por: Johnson, Joel L., et al.
Publicado: (2014)

Single and Multiple Dose Pharmacokinetics, Pharmacodynamics and Safety of the Novel Lipoprotein-Associated Phospholipase A(2) Enzyme Inhibitor Darapladib in Healthy Chinese Subjects: An Open Label Phase-1 Clinical Trial
por: Hu, Chaoying, et al.
Publicado: (2015)

Secreted phospholipase A(2), lipoprotein hydrolysis, and atherosclerosis: integration with lipidomics
por: Yamamoto, Kei, et al.
Publicado: (2011)

Elevated Lipoprotein-Associated Phospholipase A2 Is Associated With Intracranial Atherosclerosis
por: Wang, Yuan, et al.
Publicado: (2022)

Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis
por: Gong, Hui-ping, et al.
Publicado: (2011)

Inhibition of Rho-kinase is involved in the therapeutic effects of atorvastatin in heart ischemia/reperfusion
por: Cheng, Chao, et al.
Publicado: (2020)

Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk
por: Colley, Kenneth J., et al.
Publicado: (2011)

A-002 (Varespladib), a phospholipase A(2 )inhibitor, reduces atherosclerosis in guinea pigs
por: Leite, Jose O, et al.
Publicado: (2009)

Regulation of functional corneal endothelial cells isolated from sphere colonies by Rho-associated protein kinase inhibitor
por: BI, YAN-LONG, et al.
Publicado: (2013)

Association of Lipoprotein-Associated Phospholipase A(2) with Characteristics of Vulnerable Coronary Atherosclerotic Plaques
por: Liu, Yu-Sheng, et al.
Publicado: (2011)

Is Lipoprotein-Associated Phospholipase A2 a Link between Inflammation and Subclinical Atherosclerosis in Rheumatoid Arthritis?
por: Södergren, Anna, et al.
Publicado: (2015)

Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy
por: Morigny, Pauline, et al.
Publicado: (2021)

Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases
por: Wang, Qing, et al.
Publicado: (2022)

RhoA/Rho kinase in spinal cord injury
por: Wu, Xiangbing, et al.
Publicado: (2016)

Investigational Rho Kinase Inhibitors for the Treatment of Glaucoma
por: Al-Humimat, Ghadeer, et al.
Publicado: (2021)

Association between high‐sensitivity C‐reactive protein, lipoprotein‐associated phospholipase A2 and carotid atherosclerosis: A cross‐sectional study
por: Liu, Huamin, et al.
Publicado: (2018)

Tolerance of neurite outgrowth to Rho kinase inhibitors decreased by cyclooxygenase-2 inhibitor☆
por: Duan, Weigang, et al.
Publicado: (2012)

Lp-PLA(2) Selective Inhibitor (Darapladib) Effect In Lowering The Expression Level Of IL-1B And IL-6 In The Renal At Type 2 Diabetes Mellitus
por: Wihastuti, Titin Andri, et al.
Publicado: (2019)

Amelioration of atherosclerosis in apolipoprotein E-deficient mice by combined RNA interference of lipoprotein-associated phospholipase A(2) and YKL-40
por: Zhang, Hui, et al.
Publicado: (2018)

Therapeutic effect of Rho kinase inhibitor FSD-C10 in a mouse model of Alzheimer's disease
por: Gu, Qing-Fang, et al.
Publicado: (2018)

The role of Rho/Rho-kinase pathway and the neuroprotective effects of fasudil in chronic cerebral ischemia
por: Yan, Ya-yun, et al.
Publicado: (2015)

Lipids and Lipoproteins in Atherosclerosis
por: Chroni, Angeliki, et al.
Publicado: (2011)

Lipids and Lipoproteins in Atherosclerosis
por: Bezsonov, Evgeny, et al.
Publicado: (2023)

RhoA improves cryopreservation of rooster sperm through the Rho/RhoA-associated kinase/cofilin pathway
por: Heng, Nuo, et al.
Publicado: (2022)

Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A(2) and secretory phospholipase A(2) in patients with newly diagnosed type 2 diabetes
por: Lin, Xiu-hong, et al.
Publicado: (2016)

Lipoprotein‐associated phospholipase A2: The story continues
por: Huang, Fubao, et al.
Publicado: (2019)

An emerging treatment option for glaucoma: Rho kinase inhibitors
por: Wang, Sean K, et al.
Publicado: (2014)

Rho-Kinase Inhibitors as Emerging Targets for Glaucoma Therapy
por: Wang, Jun, et al.
Publicado: (2023)

Interface of Phospholipase Activity, Immune Cell Function, and Atherosclerosis
por: Schilke, Robert M., et al.
Publicado: (2020)

Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease
por: Doody, Rachelle S., et al.
Publicado: (2015)

Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis
por: Hermansson, Andreas, et al.
Publicado: (2010)

Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease
por: Ma, Kun Ling, et al.
Publicado: (2018)

Immune Response to Lipoproteins in Atherosclerosis
por: Samson, Sonia, et al.
Publicado: (2012)

Endothelial Transcytosis of Lipoproteins in Atherosclerosis
por: Zhang, Xinbo, et al.
Publicado: (2018)

Carotid Atherosclerosis, Ultrasound and Lipoproteins
por: Iannuzzi, Arcangelo, et al.
Publicado: (2021)

Lipoprotein (a), Inflammation, and Atherosclerosis
por: Di Fusco, Stefania Angela, et al.
Publicado: (2023)

Atherosclerosis Calcification: Focus on Lipoproteins
por: Neels, Jaap G., et al.
Publicado: (2023)

RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension
por: Barman, Scott A, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_sbdrurhh4pgial4s3esep3dmf5